drugset / Trial / NCT00860028

Varenicline for Smoking Cessation in Heavy Drinking Smokers

NCT00860028

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether extended pretreatment with varenicline (Chantix) is more efficacious for smoking cessation than standard pretreatment, how well varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol consumption.

Timeline

Start
2008-10
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg Oral